U.S. Gas Utilities Stock News

Kestra Medical Technologies (KMTS) has drawn investor attention after recent trading left the shares around $22.23, with a mixed return profile across the past week, month and past 3 months. See our latest analysis for Kestra Medical Technologies. The recent 14.23% 1 month share price return contrasts with weaker year to date share price performance of 8.86% and a 1 year total shareholder return of 11.50%. This suggests short term momentum has picked up while longer term returns remain under...

The United States market remained flat over the last week but has seen a notable 30% increase over the past year, with earnings forecasted to grow by 16% annually. In such an environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.

In the last week, the U.S. market has stayed flat, but over the past 12 months, it has risen by 30%, with earnings expected to grow by 16% per annum in the coming years. Amidst these conditions, identifying stocks with solid fundamentals and growth potential is crucial for investors looking to capitalize on market opportunities. Penny stocks may be an outdated term, but they still represent a valuable investment area; when backed by strong financials and balance sheet strength, these smaller...

The United States market has experienced a flat performance over the last week but has seen a significant 30% increase over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying stocks that combine strong fundamentals and growth potential can be key to uncovering hidden opportunities in the market.

If you are wondering whether Medpace Holdings at around US$421 per share is still offering value after a strong multi year run, the key is to look past the headline price and into what buyers are actually paying for the business. The stock has recently seen a 20.3% decline over 7 days and a 6.6% decline over 30 days, although the 1 year return sits at 41.3% and the 3 year return at 104.1%. Recent coverage has focused on Medpace as a contract research organization supporting clinical...

Relay Therapeutics scheduled a special call to present new clinical data on its Zovegalisib triplet therapy in breast cancer. The company plans to discuss the combination treatment results and their implications for its development programs. The announcement focuses on Zovegalisib in a triplet regimen, which may be relevant for investors following Relay Therapeutics drug pipeline. Relay Therapeutics, listed as NasdaqGM:RLAY, is drawing attention with a dedicated update on Zovegalisib, a key...

Investors may be wondering if Popular at around US$150.62 is still offering value after a strong run, or if most of the easy gains are already on the table. The stock has returned 1.4% over the last 7 days, 15.8% over the past month, 19.6% year to date, 59.5% over 1 year, 188.1% over 3 years and 128.7% over 5 years, which can change how the market views both its potential and its risks. Recent coverage has focused on Popular's position within the US banking sector and how investors are...

This article examines whether Wayfair, at around US$75.77, may still be offering value or if most of the potential upside is already reflected in the price, and breaks down what the current price might be implying. The stock has experienced notable volatility, with a 6.6% decline over the past week, a 6.0% gain over the last 30 days, a 28.9% decline year to date, and a 144.3% return over the past year. Recent coverage has focused on Wayfair's position in online home retail and how investors...

If you are wondering whether Marex Group's current share price reflects its true worth, this article walks through the key numbers that matter for value focused investors. The stock recently closed at US$53.12, with returns of 7.4% over 7 days, 23.6% over 30 days, 40.0% year to date, and 20.8% over 1 year. These figures put recent price moves front and center in any valuation discussion. Recent coverage has focused on Marex Group as a listed player in the capital markets space and on how its...

Teledyne Technologies Incorporated ( NYSE:TDY ) investors will be delighted, with the company turning in some strong...

Wondering if STAG Industrial is offering fair value at around US$39.48, or if the current price is leaving something on the table for new investors. The stock has had a mixed run recently, with a 1% decline over the last 7 days, a 9.4% gain over the last 30 days, and returns of 6.9% year to date and 25.3% over the last year. Recent coverage has focused on STAG Industrial's position in the industrial real estate space and how investors are weighing it against wider REIT options. This context...

In April 2026, Equity LifeStyle Properties, Inc. reported first-quarter 2026 results showing revenue of US$397.62 million, up from US$387.33 million a year earlier, while net income eased to US$107.9 million from US$109.19 million, and issued net income per share guidance of US$0.42–US$0.48 for the second quarter and US$2.02–US$2.12 for full-year 2026. The combination of higher revenue but slightly lower net income, alongside detailed earnings guidance, gives investors fresh insight into how...

Blue Owl Real Estate Capital has agreed to acquire Sila Realty Trust (NYSE:SILA) in an all cash merger valued at about $1.7 billion. The transaction has been unanimously approved by Sila’s board and will proceed to a shareholder vote. The deal would end Sila’s run as an independent, publicly traded, healthcare-focused real estate company. Sila Realty Trust enters this deal with its shares at $30.42 and a value score of 2, along with a 20.3% return over 5 years. More recently, the stock...

If you are wondering whether Adams Diversified Equity Fund is attractively priced at its current level, the key question is how its market price compares with its underlying portfolio value. The stock last closed at US$24.39, with returns of 1.0% over the past week, 14.5% over the past month, 4.9% year to date, 41.8% over 1 year, 112.9% over 3 years, and 115.8% over 5 years. This performance history provides multiple data points to weigh potential reward relative to risk. Recent headlines...

The United States market has shown a remarkable 30% increase over the past year, despite remaining flat over the last week, with earnings projected to grow by 16% annually. In this context, identifying small-cap stocks that are perceived as undervalued and exhibit insider buying can be an attractive strategy for investors seeking opportunities in a dynamic market environment.

The United States market has remained flat over the last week but is up 30% over the past year, with earnings forecast to grow by 16% annually. In this environment, identifying high-growth tech stocks that demonstrate strong potential for innovation and scalability can be crucial for investors looking to capitalize on these favorable conditions.

Over the last 7 days, the United States market has remained flat, yet it is up 30% over the past year with earnings expected to grow by 16% per annum in the coming years. In this environment, identifying stocks that may be trading at an estimated discount can provide opportunities for investors seeking value amidst a generally rising market.

In the last week, the United States market has stayed flat, but it is up 30% over the past year with earnings expected to grow significantly in the coming years. For investors willing to explore beyond well-known names, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities despite their vintage label. This article highlights three such penny stocks that show promise through strong financial foundations and potential for growth at lower price points.

Wondering whether JinkoSolar Holding at around US$22.27 is pricing in too much risk or not enough potential? This article breaks down what the current share price might actually reflect. The stock has been volatile recently, with a 3.7% gain over the last week, an 11.9% decline over the last month, a 20.3% decline year to date, and a 34.1% return over the past year, on top of weaker 3 year and 5 year returns of 46.2% and 27.6% respectively. Recent coverage has focused on JinkoSolar Holding...

Wondering if Manchester United shares are offering fair value or just trading on the club's global brand? This article breaks down what the current price might really be telling you. The stock last closed at US$17.22, with a 7 day return of a 3.8% decline, a 30 day return of 5.3%, a year to date return of 9.1% and a 1 year return of 24.2%. The 3 year and 5 year returns stand at a 10.0% decline and 0.5% respectively. Recent headlines around ownership, governance and the club's on field...

We can readily understand why investors are attracted to unprofitable companies. Indeed, Tenax Therapeutics...

Wondering if Deluxe at around US$30.50 is offering real value or if the big move has already happened? This article walks through what the current price is actually saying about the stock. Over the short term the share price has been fairly mixed, with a 0.2% decline over 7 days, a 13.0% gain over 30 days and a year to date return of 37.4%, while the 1 year return sits at 110.4% and the 3 year return at 146.6%, compared with a 5 year return of an 11.0% decline. Recent coverage has focused on...

It's been a good week for Halliburton Company ( NYSE:HAL ) shareholders, because the company has just released its...

Over the last year, a good number of insiders have significantly increased their holdings in Expensify, Inc...